Literature DB >> 24931489

An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.

Federico González1, Zengrong Zhu1, Zhong-Dong Shi1, Katherine Lelli1, Nipun Verma1,2, Qing V Li1,3, Danwei Huangfu1.   

Abstract

Human pluripotent stem cells (hPSCs) offer a unique platform for elucidating the genes and molecular pathways that underlie complex traits and diseases. To realize this promise, methods for rapid and controllable genetic manipulations are urgently needed. By combining two newly developed gene-editing tools, the TALEN and CRISPR/Cas systems, we have developed a genome-engineering platform in hPSCs, which we named iCRISPR. iCRISPR enabled rapid and highly efficient generation of biallelic knockout hPSCs for loss-of-function studies, as well as homozygous knockin hPSCs with specific nucleotide alterations for precise modeling of disease conditions. We further demonstrate efficient one-step generation of double- and triple-gene knockout hPSC lines, as well as stage-specific inducible gene knockout during hPSC differentiation. Thus the iCRISPR platform is uniquely suited for dissection of complex genetic interactions and pleiotropic gene functions in human disease studies and has the potential to support high-throughput genetic analysis in hPSCs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24931489      PMCID: PMC4127112          DOI: 10.1016/j.stem.2014.05.018

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  45 in total

1.  Derivation of embryonic stem-cell lines from human blastocysts.

Authors:  Chad A Cowan; Irina Klimanskaya; Jill McMahon; Jocelyn Atienza; Jeannine Witmyer; Jacob P Zucker; Shunping Wang; Cynthia C Morton; Andrew P McMahon; Doug Powers; Douglas A Melton
Journal:  N Engl J Med       Date:  2004-03-03       Impact factor: 91.245

2.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

3.  Targeting of genes to specific sites in the mammalian genome.

Authors:  K R Thomas; M R Capecchi
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

4.  Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases.

Authors:  R D Mashal; J Koontz; J Sklar
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

5.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

Review 6.  Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century.

Authors:  Mario R Capecchi
Journal:  Nat Rev Genet       Date:  2005-06       Impact factor: 53.242

7.  A TALEN genome-editing system for generating human stem cell-based disease models.

Authors:  Qiurong Ding; Youn-Kyoung Lee; Esperance A K Schaefer; Derek T Peters; Adrian Veres; Kevin Kim; Nicolas Kuperwasser; Daniel L Motola; Torsten B Meissner; William T Hendriks; Marta Trevisan; Rajat M Gupta; Annie Moisan; Eric Banks; Max Friesen; Robert T Schinzel; Fang Xia; Alexander Tang; Yulei Xia; Emmanuel Figueroa; Amy Wann; Tim Ahfeldt; Laurence Daheron; Feng Zhang; Lee L Rubin; Lee F Peng; Raymond T Chung; Kiran Musunuru; Chad A Cowan
Journal:  Cell Stem Cell       Date:  2012-12-13       Impact factor: 24.633

8.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

9.  Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.

Authors:  Shinsuke Ito; Ana C D'Alessio; Olena V Taranova; Kwonho Hong; Lawrence C Sowers; Yi Zhang
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

View more
  197 in total

1.  The iCRISPR platform for rapid genome editing in human pluripotent stem cells.

Authors:  Zengrong Zhu; Federico González; Danwei Huangfu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 2.  Genome editing: a robust technology for human stem cells.

Authors:  Arun Pandian Chandrasekaran; Minjung Song; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

3.  Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development.

Authors:  Zhong-Dong Shi; Kihyun Lee; Dapeng Yang; Sadaf Amin; Nipun Verma; Qing V Li; Zengrong Zhu; Chew-Li Soh; Ritu Kumar; Todd Evans; Shuibing Chen; Danwei Huangfu
Journal:  Cell Stem Cell       Date:  2017-02-09       Impact factor: 24.633

4.  Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.

Authors:  Florian T Merkle; Werner M Neuhausser; David Santos; Eivind Valen; James A Gagnon; Kristi Maas; Jackson Sandoe; Alexander F Schier; Kevin Eggan
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

5.  Simultaneous reprogramming and gene editing of human fibroblasts.

Authors:  Sara E Howden; James A Thomson; Melissa H Little
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

6.  Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells.

Authors:  Steven Havlicek; Yang Shen; Yunus Alpagu; Michaela B Bruntraeger; Nurdiana B M Zufir; Zhi Yi Phuah; Zhiyan Fu; Norris R Dunn; Lawrence W Stanton
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

7.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

Authors:  Hachung Chung; Jorg J A Calis; Xianfang Wu; Tony Sun; Yingpu Yu; Stephanie L Sarbanes; Viet Loan Dao Thi; Abigail R Shilvock; H-Heinrich Hoffmann; Brad R Rosenberg; Charles M Rice
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

Review 8.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

Review 9.  Use of human pluripotent stem cells to study and treat retinopathies.

Authors:  Karim Ben M'Barek; Florian Regent; Christelle Monville
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

10.  LNA modification of single-stranded DNA oligonucleotides allows subtle gene modification in mismatch-repair-proficient cells.

Authors:  Thomas W van Ravesteyn; Marleen Dekker; Alexander Fish; Titia K Sixma; Astrid Wolters; Rob J Dekker; Hein P J Te Riele
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.